Everhart Financial Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$715K	Buy	2,193 +406	+23%	+$132K	0.08%	179
2025 Q1	$483K	Buy	1,787 +191	+12%	+$51.6K	0.07%	212
2024 Q4	$376K	Sell	1,596 -110	-6%	-$25.9K	0.08%	231
2024 Q3	$469K	Buy	1,706 +384	+29%	+$106K	0.1%	201
2024 Q2	$321K	Buy	+1,322	New	+$321K	0.08%	217